P1005 (DAIDS ID 10314): A Phase I/II Study of T-20, a Fusion Inhibitor, in HIV-1-Infected Children
| Study Status | Study Restriction |
|---|---|
Concluded |
Not Applicable |
Sites where the study was implemented:
| CRS ID | Site Name | City | Country |
|---|---|---|---|
UCSD Mother-Child-Adolescent HIV Program |
San Diego |
United States of America |
|
Boston Medical Center Pediatric HIV Program |
Boston |
United States of America |
Study contacts:
| No records returned. | ||||